Top Markets
#1 Islamic Coin Islamic Coin +154.32%
#2 PulseChain PulseChain +49.10%
#3 DogBull DogBull +35.82%
#4 BOOK OF MEME BOOK OF MEME +33.86%
#5 Ergo Ergo +24.35%
#6 Bio Protocol Bio Protocol +19.63%
#7 rsERG rsERG +19.52%
#8 Janction Janction +17.57%
#9 RedStone RedStone +14.71%
#10 edgeX edgeX +13.89%
Coin of the day
Islamic Coin Islamic Coin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Cytocom, Inc. Cytocom, Inc.

Cytocom, Inc.

CBLI
Pozycja w akcjach #27154
Cleveland BioLabs, Inc. functions as a biopharmaceutical firm, specializing in... Cleveland BioLabs, Inc. functions as a biopharmaceutical firm, specializing in the discovery and advancement of therapeutic drugs. Based in Buffalo, New York, the organization maintains a modest workforce of 15 full-time employees. Its primary objective involves pioneering methods to stimulate the body's immune defenses to tackle significant medical challenges. A core component of its work is a platform utilizing Toll-like immune receptor activators, which demonstrates utility in both alleviating radiation-induced damage and in the field of immuno-oncology. The most advanced therapeutic candidate in its pipeline is Entolimod, an immune-stimulating compound currently under development as a protective measure against radiation exposure and as an immunotherapy for various cancers and other indications. The company's portfolio also encompasses other promising products, including CBLB612, Mobilan, and CBL0137. CBLB612 is formulated from a natural stimulant that targets a specific component of the innate immune system: the heterodimeric receptor formed by toll-like receptors 2 (TLR2) and 6 (TLR6). Mobilan is a recombinant, non-replicating adenovirus engineered to induce the expression of TLR5 and its corresponding agonistic ligand. Lastly, CBL0137 is a small molecule characterized by a multi-faceted mechanism of action, suggesting its potential effectiveness across diverse forms of cancer.
Cena akcji
$3.17
Ostatnia synchronizacja: 2021-08-31
Kapitalizacja rynkowa
$34.83M
Zmiana (1 dzień)
-7.31%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Cytocom, Inc. (CBLI)

Kategoria

Healthcare
Historia stopy dywidendy dla Cytocom, Inc. (CBLI)
Stopa dywidendy (TTM) dla Cytocom, Inc. (symbol akcji: CBLI) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Cytocom, Inc. (CBLI) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH